vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Mobileye Global Inc. (MBLY). Click either name above to swap in a different company.

Mobileye Global Inc. is the larger business by last-quarter revenue ($1.9B vs $1.0B, roughly 1.9× Alignment Healthcare, Inc.). On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 27.4%). Over the past eight quarters, Mobileye Global Inc.'s revenue compounded faster (109.9% CAGR vs 26.9%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Mobileye Global Inc. is a United States-domiciled, Israel-headquartered autonomous driving company. It is developing self-driving technologies and advanced driver-assistance systems (ADAS) including cameras, computer chips, and software. Mobileye was acquired by Intel in 2017 and went public again in 2022.

ALHC vs MBLY — Head-to-Head

Bigger by revenue
MBLY
MBLY
1.9× larger
MBLY
$1.9B
$1.0B
ALHC
Growing faster (revenue YoY)
ALHC
ALHC
+17.0% gap
ALHC
44.4%
27.4%
MBLY
Faster 2-yr revenue CAGR
MBLY
MBLY
Annualised
MBLY
109.9%
26.9%
ALHC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALHC
ALHC
MBLY
MBLY
Revenue
$1.0B
$1.9B
Net Profit
$-11.0M
Gross Margin
14.2%
Operating Margin
-1.0%
Net Margin
-1.1%
Revenue YoY
44.4%
27.4%
Net Profit YoY
64.6%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
MBLY
MBLY
Q1 26
$1.9B
Q4 25
$1.0B
$446.0M
Q3 25
$993.7M
$504.0M
Q2 25
$1.0B
$506.0M
Q1 25
$926.9M
$438.0M
Q4 24
$701.2M
$490.0M
Q3 24
$692.4M
$486.0M
Q2 24
$681.3M
$439.0M
Net Profit
ALHC
ALHC
MBLY
MBLY
Q1 26
Q4 25
$-11.0M
$-127.0M
Q3 25
$3.7M
$-96.0M
Q2 25
$15.7M
$-67.0M
Q1 25
$-9.1M
$-102.0M
Q4 24
$-31.1M
$-71.0M
Q3 24
$-26.4M
$-2.7B
Q2 24
$-24.0M
$-86.0M
Gross Margin
ALHC
ALHC
MBLY
MBLY
Q1 26
14.2%
Q4 25
45.3%
Q3 25
48.2%
Q2 25
49.8%
Q1 25
47.3%
Q4 24
49.2%
Q3 24
48.8%
Q2 24
47.6%
Operating Margin
ALHC
ALHC
MBLY
MBLY
Q1 26
Q4 25
-1.0%
-31.4%
Q3 25
0.8%
-21.6%
Q2 25
2.2%
-14.6%
Q1 25
-0.6%
-26.7%
Q4 24
-3.2%
-17.6%
Q3 24
-2.8%
-577.6%
Q2 24
-2.7%
-21.4%
Net Margin
ALHC
ALHC
MBLY
MBLY
Q1 26
Q4 25
-1.1%
-28.5%
Q3 25
0.4%
-19.0%
Q2 25
1.5%
-13.2%
Q1 25
-1.0%
-23.3%
Q4 24
-4.4%
-14.5%
Q3 24
-3.8%
-558.6%
Q2 24
-3.5%
-19.6%
EPS (diluted)
ALHC
ALHC
MBLY
MBLY
Q1 26
Q4 25
$-0.04
$-0.15
Q3 25
$0.02
$-0.12
Q2 25
$0.07
$-0.08
Q1 25
$-0.05
$-0.13
Q4 24
$-0.15
$-0.09
Q3 24
$-0.14
$-3.35
Q2 24
$-0.13
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
MBLY
MBLY
Cash + ST InvestmentsLiquidity on hand
$604.2M
$1.2B
Total DebtLower is stronger
$323.2M
Stockholders' EquityBook value
$179.3M
$8.2B
Total Assets
$1.1B
$8.7B
Debt / EquityLower = less leverage
1.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
MBLY
MBLY
Q1 26
$1.2B
Q4 25
$604.2M
$1.8B
Q3 25
$644.1M
$1.7B
Q2 25
$503.8M
$1.7B
Q1 25
$479.5M
$1.5B
Q4 24
$470.6M
$1.4B
Q3 24
$381.0M
$1.3B
Q2 24
$363.7M
$1.2B
Total Debt
ALHC
ALHC
MBLY
MBLY
Q1 26
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Stockholders' Equity
ALHC
ALHC
MBLY
MBLY
Q1 26
$8.2B
Q4 25
$179.3M
$11.9B
Q3 25
$161.9M
$11.9B
Q2 25
$141.0M
$12.1B
Q1 25
$108.1M
$12.0B
Q4 24
$99.9M
$12.1B
Q3 24
$114.5M
$12.1B
Q2 24
$123.7M
$14.7B
Total Assets
ALHC
ALHC
MBLY
MBLY
Q1 26
$8.7B
Q4 25
$1.1B
$12.5B
Q3 25
$1.1B
$12.5B
Q2 25
$1.0B
$12.6B
Q1 25
$895.6M
$12.5B
Q4 24
$782.1M
$12.6B
Q3 24
$692.3M
$12.6B
Q2 24
$716.3M
$15.3B
Debt / Equity
ALHC
ALHC
MBLY
MBLY
Q1 26
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
MBLY
MBLY
Operating Cash FlowLast quarter
$-50.4M
$75.0M
Free Cash FlowOCF − Capex
$-55.4M
FCF MarginFCF / Revenue
-5.5%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$113.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
MBLY
MBLY
Q1 26
$75.0M
Q4 25
$-50.4M
$113.0M
Q3 25
$144.6M
$167.0M
Q2 25
$29.1M
$213.0M
Q1 25
$16.6M
$109.0M
Q4 24
$-8.7M
$204.0M
Q3 24
$26.2M
$126.0M
Q2 24
$23.5M
$30.0M
Free Cash Flow
ALHC
ALHC
MBLY
MBLY
Q1 26
Q4 25
$-55.4M
$86.0M
Q3 25
$139.1M
$143.0M
Q2 25
$21.1M
$199.0M
Q1 25
$8.4M
$95.0M
Q4 24
$-18.0M
$191.0M
Q3 24
$16.9M
$104.0M
Q2 24
$11.8M
$6.0M
FCF Margin
ALHC
ALHC
MBLY
MBLY
Q1 26
Q4 25
-5.5%
19.3%
Q3 25
14.0%
28.4%
Q2 25
2.1%
39.3%
Q1 25
0.9%
21.7%
Q4 24
-2.6%
39.0%
Q3 24
2.4%
21.4%
Q2 24
1.7%
1.4%
Capex Intensity
ALHC
ALHC
MBLY
MBLY
Q1 26
Q4 25
0.5%
6.1%
Q3 25
0.6%
4.8%
Q2 25
0.8%
2.8%
Q1 25
0.9%
3.2%
Q4 24
1.3%
2.7%
Q3 24
1.3%
4.5%
Q2 24
1.7%
5.5%
Cash Conversion
ALHC
ALHC
MBLY
MBLY
Q1 26
Q4 25
Q3 25
38.77×
Q2 25
1.86×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons